Showing results (2071-2080 of 2,519) with videos related to

Sort By:
Pageof 252
Kidney International|September 24, 2021
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney functionHiddo J L Heerspink, David Cherney, Douwe Postmus, et al.
The Journal of Biological Chemistry|July 29, 2011
Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channelsMelissa Miller, Jie Shi, Yingmin Zhu, et al.
Cancer Research|October 3, 2008
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumorsJoo Mi Yi, Hsing-Chen Tsai, Sabine C Glöckner, et al.
Biomedical Chromatography : BMC|June 30, 2020
A volatolomic approach using cerumen as biofluid to diagnose bovine intoxication by Stryphnodendron rotundifoliumJoão Marcos G Barbosa, Milenna K Fernandes Rodrigues, Lurian C David, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 1, 2021
Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trialDavid C Wheeler, Niels Jongs, Bergur V Stefansson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 26, 2009
First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorderSancy A Leachman, Robyn P Hickerson, Mary E Schwartz, et al.
European Journal of Medicinal Chemistry|May 11, 2020
Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's diseaseJulio Rodríguez-Lavado, Carlos Gallardo-Garrido, Michael Mallea, et al.
JACC. Cardiovascular Imaging|January 17, 2021
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery DiseaseTamique Mason, Otavio R Coelho-Filho, Subodh Verma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2021
The radiotherapy quality assurance gap among phase III cancer clinical trialsKelsey L Corrigan, Stephen Kry, Rebecca M Howell, et al.
Kidney International|April 20, 2021
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathyDavid C Wheeler, Robert D Toto, Bergur V Stefánsson, et al.
Pageof 252